Summary
A 55-year-old control systems specialist, holding a security clearance since 2009, had his eligibility for access to classified information reviewed under Guideline H (Drug Involvement). The Statement of Reasons alleged that the applicant used and purchased marijuana (THC) with varying frequency from approximately October 2022 to December 2022, while already possessing a security clearance or being in a sensitive position. This raised disqualifying conditions under Adjudicative Guidelines (AG) ¶ 25(a) and AG ¶ 25(c).
However, the applicant successfully mitigated these concerns. He voluntarily disclosed his past marijuana use and ceased all use prior to his security clearance renewal. The applicant demonstrated a clear willingness to comply with laws and regulations concerning drug use.
Ultimately, the judge determined that the applicant's limited and infrequent drug involvement did not cast doubt on his current reliability or trustworthiness. Mitigating conditions AG ¶ 26(a) and AG ¶ 26(b) were applied, leading to a favorable decision. The applicant was GRANTED eligibility for access to classified information.
Why the Applicant Prevailed
- The applicant voluntarily disclosed his past marijuana use and ceased using it prior to his security clearance renewal.
- He demonstrated a willingness to comply with laws and regulations regarding drug use.
- The applicant's limited and infrequent drug involvement did not cast doubt on his current reliability or trustworthiness.
Conditions Referenced
- AG ¶ 25(a)raisedIllegal Possession of a Controlled Substance
- AG ¶ 25(c)raisedAny Substance Misuse
- AG ¶ 26(a)appliedBehavior Happened so Long Ago, Was Infrequent, or Unlikely to Recur
- AG ¶ 26(b)appliedAcknowledgment of Drug Involvement and Evidence of Actions Taken to Overcome the Problem
Key Rule Quoted
“Eligibility for a security clearance is predicated upon the applicant meeting the criteria contained in the adjudicative guidelines.”
Procedural Posture
- SOR issuedOct 24, 2023
- Answer filedNov 27, 2023
- Hearing heldAug 26, 2024
- Decision dateAug 26, 2024
Cite For
- Mitigation of Drug Involvement Under Guideline H
- Voluntary Disclosure of Past Drug Use as a Mitigating Factor
- Consideration of the Whole-person Concept in Security Clearance Decisions